A Biorepository of Induced Pluripotent Stem Cells from Subjects with Liver Disease

Overview

About this study

The purpose of this study is to develop stem cells from cells within patients’ skin. Stem cells are a unique type of cell capable of converting into multiple other adult cell types. The stem cells will later be converted to liver cells and used to better understand liver disease and help develop treatments.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age 18 years or older.
  • Able to provide written or verbal informed consent.
  • Healthy volunteers or patients diagnosed with suspected, possible, probable, or definite chronic liver disease by a Mayo hepatologist or liver surgeon.

Exclusion Criteria:

  • Age 17 years and younger.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Robert Huebert, M.D.

Closed for enrollment

Contact information:

Mary Devine M.S., CCRP

FelmleeDevine.Donna@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Jorge Rakela, M.D.

Closed for enrollment

Contact information:

Mary Devine M.S., CCRP

FelmleeDevine.Donna@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20492738

Mayo Clinic Footer